These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 11518802

  • 1. Aberrant alternative splicing of thyroid hormone receptor in a TSH-secreting pituitary tumor is a mechanism for hormone resistance.
    Ando S, Sarlis NJ, Krishnan J, Feng X, Refetoff S, Zhang MQ, Oldfield EH, Yen PM.
    Mol Endocrinol; 2001 Sep; 15(9):1529-38. PubMed ID: 11518802
    [Abstract] [Full Text] [Related]

  • 2. Somatic mutation of TRbeta can cause a defect in negative regulation of TSH in a TSH-secreting pituitary tumor.
    Ando S, Sarlis NJ, Oldfield EH, Yen PM.
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5572-6. PubMed ID: 11701737
    [Abstract] [Full Text] [Related]

  • 3. Aberrant expression of thyroid hormone receptor beta isoform may cause inappropriate secretion of TSH in a TSH-secreting pituitary adenoma.
    Tagami T, Usui T, Shimatsu A, Beniko M, Yamamoto H, Moriyama K, Naruse M.
    J Clin Endocrinol Metab; 2011 Jun; 96(6):E948-52. PubMed ID: 21430027
    [Abstract] [Full Text] [Related]

  • 4. An abnormality of thyroid hormone receptor expression may explain abnormal thyrotropin production in thyrotropin-secreting pituitary tumors.
    Gittoes NJ, McCabe CJ, Verhaeg J, Sheppard MC, Franklyn JA.
    Thyroid; 1998 Jan; 8(1):9-14. PubMed ID: 9492147
    [Abstract] [Full Text] [Related]

  • 5. A pituitary tumor in a patient with thyroid hormone resistance: a diagnostic dilemma.
    Safer JD, Colan SD, Fraser LM, Wondisford FE.
    Thyroid; 2001 Mar; 11(3):281-91. PubMed ID: 11327621
    [Abstract] [Full Text] [Related]

  • 6. An unliganded thyroid hormone beta receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis.
    Furumoto H, Ying H, Chandramouli GV, Zhao L, Walker RL, Meltzer PS, Willingham MC, Cheng SY.
    Mol Cell Biol; 2005 Jan; 25(1):124-35. PubMed ID: 15601836
    [Abstract] [Full Text] [Related]

  • 7. Pituitary resistance to thyroid hormone syndrome is associated with T3 receptor mutants that selectively impair beta2 isoform function.
    Wan W, Farboud B, Privalsky ML.
    Mol Endocrinol; 2005 Jun; 19(6):1529-42. PubMed ID: 15802373
    [Abstract] [Full Text] [Related]

  • 8. Isoform variable action among thyroid hormone receptor mutants provides insight into pituitary resistance to thyroid hormone.
    Safer JD, Langlois MF, Cohen R, Monden T, John-Hope D, Madura J, Hollenberg AN, Wondisford FE.
    Mol Endocrinol; 1997 Jan; 11(1):16-26. PubMed ID: 8994184
    [Abstract] [Full Text] [Related]

  • 9. Dominant inhibition of thyroid hormone action selectively in the pituitary of thyroid hormone receptor-beta null mice abolishes the regulation of thyrotropin by thyroid hormone.
    Abel ED, Moura EG, Ahima RS, Campos-Barros A, Pazos-Moura CC, Boers ME, Kaulbach HC, Forrest D, Wondisford FE.
    Mol Endocrinol; 2003 Sep; 17(9):1767-76. PubMed ID: 12819298
    [Abstract] [Full Text] [Related]

  • 10. A Patient With a Thyrotropin-Secreting Microadenoma and Resistance to Thyroid Hormone (P453T).
    Teng X, Jin T, Brent GA, Wu A, Teng W, Shan Z.
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2511-4. PubMed ID: 25867808
    [Abstract] [Full Text] [Related]

  • 11. Five new families with resistance to thyroid hormone not caused by mutations in the thyroid hormone receptor beta gene.
    Pohlenz J, Weiss RE, Macchia PE, Pannain S, Lau IT, Ho H, Refetoff S.
    J Clin Endocrinol Metab; 1999 Nov; 84(11):3919-28. PubMed ID: 10566629
    [Abstract] [Full Text] [Related]

  • 12. Clinical and genetic characteristics of a large monocentric series of patients affected by thyroid hormone (Th) resistance and suggestions for differential diagnosis in patients without mutation of Th receptor β.
    Macchia E, Lombardi M, Raffaelli V, Piaggi P, Macchia L, Scattina I, Martino E.
    Clin Endocrinol (Oxf); 2014 Dec; 81(6):921-8. PubMed ID: 25040256
    [Abstract] [Full Text] [Related]

  • 13. Clinical and molecular features of a TSH-secreting pituitary microadenoma.
    Usui T, Izawa S, Sano T, Tagami T, Nagata D, Shimatsu A, Takahashi JA, Naruse M.
    Pituitary; 2005 Dec; 8(2):127-34. PubMed ID: 16379036
    [Abstract] [Full Text] [Related]

  • 14. Liganded T3 receptor β2 inhibits the positive feedback autoregulation of the gene for GATA2, a transcription factor critical for thyrotropin production.
    Hirahara N, Nakamura HM, Sasaki S, Matsushita A, Ohba K, Kuroda G, Sakai Y, Shinkai S, Haeno H, Nishio T, Yoshida S, Oki Y, Suda T.
    PLoS One; 2020 Dec; 15(1):e0227646. PubMed ID: 31940421
    [Abstract] [Full Text] [Related]

  • 15. Differential regulation of thyroid hormone receptor messenger ribonucleic acid levels by thyrotropin-releasing hormone.
    Jones KE, Chin WW.
    Endocrinology; 1991 Apr; 128(4):1763-8. PubMed ID: 1900776
    [Abstract] [Full Text] [Related]

  • 16. Endocrine and immunohistochemical studies on thyrotropin (TSH)-secreting pituitary adenomas: responses of TSH, alpha-subunit, and growth hormone to hypothalamic releasing hormones and their distribution in adenoma cells.
    Kuzuya N, Inoue K, Ishibashi M, Murayama Y, Koide Y, Ito K, Yamaji T, Yamashita K.
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1103-11. PubMed ID: 1699960
    [Abstract] [Full Text] [Related]

  • 17. Thyroid receptor alpha1 and alpha2 mutations in nonfunctioning pituitary tumors.
    McCabe CJ, Gittoes NJ, Sheppard MC, Franklyn JA.
    J Clin Endocrinol Metab; 1999 Feb; 84(2):649-53. PubMed ID: 10022432
    [Abstract] [Full Text] [Related]

  • 18. Both thyroid hormone receptor (TR)beta 1 and TR beta 2 isoforms contribute to the regulation of hypothalamic thyrotropin-releasing hormone.
    Dupré SM, Guissouma H, Flamant F, Seugnet I, Scanlan TS, Baxter JD, Samarut J, Demeneix BA, Becker N.
    Endocrinology; 2004 May; 145(5):2337-45. PubMed ID: 14726446
    [Abstract] [Full Text] [Related]

  • 19. Thyroid-hormone-dependent negative regulation of thyrotropin beta gene by thyroid hormone receptors: study with a new experimental system using CV1 cells.
    Nakano K, Matsushita A, Sasaki S, Misawa H, Nishiyama K, Kashiwabara Y, Nakamura H.
    Biochem J; 2004 Mar 01; 378(Pt 2):549-57. PubMed ID: 14611644
    [Abstract] [Full Text] [Related]

  • 20. Spectrum of transcriptional, dimerization, and dominant negative properties of twenty different mutant thyroid hormone beta-receptors in thyroid hormone resistance syndrome.
    Collingwood TN, Adams M, Tone Y, Chatterjee VK.
    Mol Endocrinol; 1994 Sep 01; 8(9):1262-77. PubMed ID: 7838159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.